As the name suggests, two scFv units are linked in sequence to constitute a tandem scFv, characterized by dual antigen-binding sites. This tandem scFv is produced through mammalian cell transfection, wherein four variable domains arranged in series are joined by adaptable peptide linkers. The absence of an Fc segment results in a reduced molecular mass (approximately 55 kDa), leading to a brief plasma half-life; however, this compact structure simultaneously facilitates nearer engagement with the two antigens or the membranes of target cells. Building upon the tandem scFv framework, additional scFv units can be concatenated to generate multispecific or bispecific, multivalent BsAbs. Furthermore, the CH3 domain from Fc regions is incorporated into the tandem scFv to prolong its circulation time and incorporate Fc-mediated effector activities, yielding constructs such as tandem scFv-CH3 or tandem scFv-Fc.
Fig.1 Tandem scFv.Distributed under Publish Domain, from Wiki, without modification
Are you currently facing compromised thermal stability, short systemic half-life, or complex purification of bispecific heterodimers? Our Tandem scFv Generation Service helps you accelerate drug discovery and obtain high-quality, stable BsAbs through advanced Fc-fusion and Knobs-into-Holes (KiH) engineering.
Find more Tandem scFv, and contact our team to get an inquiry now!
Tandem scFv in Immunology
Because malignant cells evade regulatory pathways of T-cell activity under selection, the anticancer efficacy of T-cells is often partially inadequate. Enhanced insights into immune evasion processes have led to the development of various innovative immunotherapeutic approaches centered on T-cells. Among these, bispecific antibodies represent a promising tactic. The tandem scFv demonstrates a potency in destroying tumor cells that is several orders of magnitude greater than that of other CD3-bispecific antibodies or conventional IgG molecules. These characteristics collectively establish it as a paramount agent for recruiting T-cells in oncology and immunomodulation.
Choosing Creative Biolabs means leveraging two decades of specialized expertise in protein engineering to solve the stability and manufacturability challenges that plague novel therapeutic formats. We don't just produce fragments; we engineer next-generation clinical candidates.
Experience the Creative Biolabs Advantage - Get a Quote Today
A: The compact, two-binding-domain structure of our Tandem scFv-Fc is designed for ultra-high potency. By maximizing the geometric proximity between the target cell and the CD3 receptor on the T-cell, these molecules are often demonstrated to be thousands of times more efficient at inducing lytic activity than bulky, full IgG bispecifics. We recommend discussing your specific E:T ratio requirements with our team.
A: This is the primary reason we focus on the Tandem scFv-Fc format. By adding the Fc fusion, we provide structural reinforcement, moving the thermal denaturation temperature (Tm) from the problematic 50℃–60℃ range up to a more robust 70℃–75℃. This stability is crucial for downstream processes like purification, concentration, and long-term storage.
A: No, only the VH and VL sequence information (either DNA or amino acid) for your desired binding arms is required. We handle all aspects of codon optimization, gene synthesis, and Fc engineering in-house to build the optimal Tandem scFv-Fc construct from the ground up.
A: Absolutely. We routinely engineer the Fc domain using established mutations to silence Fc effector function entirely. This provides the half-life benefit of the FcRn pathway without triggering native immune responses—a key feature for T-cell redirection. Please specify your Fc requirement when you inquire.
A: KiH is specifically used when generating a bivalent/bispecific molecule requiring two different Fc heavy chains to heterodimerize. If you require a monovalent BsAb (e.g., using a Fab fusion or alternative design), we would employ a different, equally effective engineering strategy tailored to monovalency. Discussing your valency requirement with us is the best next step.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY
SERVICES
PRODUCTS
PLATFORMS
